Additionally, the study on hepatocellular cancer suggest that the cohort exhibited a higher sensitivity to hPG80 than AFP, the common prognostic biomarker used for hepatocellular carcinoma, where combined measurement of hPG80 and AFP (clinical cut-point at 100 ng/mL) improved prognosis for patients with low AFP [20]. Here, AFP is linked to hepatocellular carcinoma.